From: Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on Glucose tolerance and ENdothelial function - a crossover Trial (AGENT)
Baseline
Azelnidipine
N = 17
Amlodipine
P**
SBP (mmHg)
119.9 ± 11.5
120.2 ± 11.7
121.3 ± 8.6
0.492
DBP (mmHg)
71.6 ± 10.6
66.8 ± 7.2
70.1 ± 8.4
0.145
Heart rate
64.9 ± 5.9
60.5 ± 6.6*
65.1 ± 7.6
0.003